# An Expanded Safety Study of Dapivirine Gel 4789 in Africa

> **NCT00917904** · PHASE1,PHASE2 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 100 (actual)

## Conditions studied

- HIV Infections
- Acquired Immunodeficiency Syndrome
- Healthy

## Interventions

- **DRUG:** dapivirine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00917904
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917904, "An Expanded Safety Study of Dapivirine Gel 4789 in Africa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00917904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*